Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$76.29
At close: Mar 31, 4:36 PM EDT
$76.29
0.000.00%
After Hours: 4:36 PM EDT
Comments
Loading...
Insmed Analyst Ratings and Price Targets | NASDAQ:INSM | Benzinga
Insmed Inc has a consensus price target of $84.26 based on the ratings of 21 analysts. The high is $110 issued by UBS on March 6, 2025. The low is $42 issued by Wolfe Research on February 15, 2024. The 3 most-recent analyst ratings were released by B of A Securities, RBC Capital, and UBS on March 20, 2025, March 19, 2025, and March 6, 2025, respectively. With an average price target of $102 between B of A Securities, RBC Capital, and UBS, there's an implied 33.70% upside for Insmed Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
B of A Securities
RBC Capital
UBS
Guggenheim
HC Wainwright & Co.
1calculated from analyst ratings
Analyst Ratings for Insmed
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/20/2025 | Buy Now | 25.84% | B of A Securities | Jason Zemansky74% | $92 → $96 | Maintains | Buy | Get Alert |
| 03/19/2025 | Buy Now | 31.08% | RBC Capital | Leonid Timashev43% | $100 → $100 | Reiterates | Outperform → Outperform | Get Alert |
| 03/06/2025 | Buy Now | 44.19% | UBS | Trung Huynh69% | $105 → $110 | Maintains | Buy | Get Alert |
| 02/25/2025 | Buy Now | 31.08% | RBC Capital | Leonid Timashev43% | → $100 | Initiates | → Outperform | Get Alert |
| 02/25/2025 | Buy Now | 32.39% | Guggenheim | Vamil Divan75% | $101 → $101 | Reiterates | Buy → Buy | Get Alert |
| 02/24/2025 | Buy Now | 17.97% | HC Wainwright & Co. | Andrew Fein62% | $90 → $90 | Reiterates | Buy → Buy | Get Alert |
| 02/21/2025 | Buy Now | 41.57% | Truist Securities | Nicole Germino51% | $105 → $108 | Maintains | Buy | Get Alert |
| 02/21/2025 | Buy Now | 25.84% | Stifel | Stephen Willey54% | $97 → $96 | Maintains | Buy | Get Alert |
| 02/21/2025 | Buy Now | 17.97% | HC Wainwright & Co. | Andrew Fein62% | $90 → $90 | Reiterates | Buy → Buy | Get Alert |
| 02/20/2025 | Buy Now | — | Cantor Fitzgerald | Jennifer Kim47% | — | Reiterates | Overweight → Overweight | Get Alert |
| 02/19/2025 | Buy Now | — | Cantor Fitzgerald | Jennifer Kim47% | — | Reiterates | Overweight → Overweight | Get Alert |
| 02/19/2025 | Buy Now | 40.25% | Wells Fargo | Tiago Fauth70% | $85 → $107 | Maintains | Overweight | Get Alert |
| 02/11/2025 | Buy Now | 27.15% | Stifel | Stephen Willey54% | $88 → $97 | Maintains | Buy | Get Alert |
| 02/07/2025 | Buy Now | 20.59% | JP Morgan | Jessica Fye72% | $83 → $92 | Maintains | Overweight | Get Alert |
| 02/07/2025 | Buy Now | 32.39% | Guggenheim | Vamil Divan75% | $95 → $101 | Maintains | Buy | Get Alert |
| 02/06/2025 | Buy Now | 17.97% | Morgan Stanley | Matthew Harrison32% | $85 → $90 | Maintains | Overweight | Get Alert |
| 11/22/2024 | Buy Now | 8.8% | JP Morgan | Jessica Fye72% | $74 → $83 | Maintains | Overweight | Get Alert |
| 11/01/2024 | Buy Now | 37.63% | Truist Securities | Nicole Germino51% | $100 → $105 | Reiterates | Buy → Buy | Get Alert |
| 11/01/2024 | Buy Now | 17.97% | HC Wainwright & Co. | Andrew Fein62% | $90 → $90 | Reiterates | Buy → Buy | Get Alert |
| 10/11/2024 | Buy Now | 31.08% | Truist Securities | Nicole Germino51% | $85 → $100 | Maintains | Buy | Get Alert |
| 10/09/2024 | Buy Now | 12.73% | B of A Securities | Jason Zemansky74% | $84 → $86 | Maintains | Buy | Get Alert |
| 10/03/2024 | Buy Now | -3% | JP Morgan | Jessica Fye72% | $72 → $74 | Maintains | Overweight | Get Alert |
| 09/09/2024 | Buy Now | — | Cantor Fitzgerald | Josh Schimmer54% | — | Reiterates | → Overweight | Get Alert |
| 08/29/2024 | Buy Now | 17.97% | HC Wainwright & Co. | Andrew Fein62% | $90 → $90 | Reiterates | Buy → Buy | Get Alert |
| 08/12/2024 | Buy Now | 11.42% | Truist Securities | Nicole Germino51% | $88 → $85 | Maintains | Buy | Get Alert |
| 08/12/2024 | Buy Now | 17.97% | HC Wainwright & Co. | Andrew Fein62% | $90 → $90 | Reiterates | Buy → Buy | Get Alert |
| 08/09/2024 | Buy Now | 28.46% | TD Cowen | Ritu Baral31% | $75 → $98 | Maintains | Buy | Get Alert |
| 08/09/2024 | Buy Now | 10.11% | UBS | Trung Huynh69% | $78 → $84 | Maintains | Buy | Get Alert |
| 08/09/2024 | Buy Now | 15.35% | Stifel | Stephen Willey54% | $74 → $88 | Maintains | Buy | Get Alert |
| 07/12/2024 | Buy Now | 11.42% | Morgan Stanley | Matthew Harrison32% | $60 → $85 | Maintains | Overweight | Get Alert |
| 07/10/2024 | Buy Now | 33.7% | Goldman Sachs | Andrea Tan44% | $74 → $102 | Maintains | Buy | Get Alert |
| 07/09/2024 | Buy Now | 24.52% | Guggenheim | Vamil Divan75% | $70 → $95 | Maintains | Buy | Get Alert |
| 07/08/2024 | Buy Now | 17.97% | HC Wainwright & Co. | Andrew Fein62% | $70 → $90 | Maintains | Buy | Get Alert |
| 07/05/2024 | Buy Now | 8.8% | B of A Securities | Jason Zemansky74% | $83 → $83 | Maintains | Buy | Get Alert |
| 07/02/2024 | Buy Now | -8.24% | HC Wainwright & Co. | Andrew Fein62% | $70 → $70 | Reiterates | Buy → Buy | Get Alert |
| 07/01/2024 | Buy Now | 15.35% | Truist Securities | Nicole Germino51% | $68 → $88 | Maintains | Buy | Get Alert |
| 06/28/2024 | Buy Now | 8.8% | B of A Securities | Jason Zemansky74% | $62 → $83 | Maintains | Buy | Get Alert |
| 06/21/2024 | Buy Now | -1.69% | Evercore ISI Group | Josh Schimmer54% | $42 → $75 | Maintains | Outperform | Get Alert |
| 06/20/2024 | Buy Now | — | Cantor Fitzgerald | Jennifer Kim47% | — | Reiterates | → Overweight | Get Alert |
| 06/20/2024 | Buy Now | -5.62% | JP Morgan | Jessica Fye72% | $55 → $72 | Maintains | Overweight | Get Alert |
| 06/07/2024 | Buy Now | 7.48% | Mizuho | Graig Suvannavejh48% | $36 → $82 | Maintains | Buy | Get Alert |
| 06/05/2024 | Buy Now | -3% | Stifel | Stephen Willey54% | $67 → $74 | Maintains | Buy | Get Alert |
| 05/31/2024 | Buy Now | -12.18% | Stifel | Stephen Willey54% | $39 → $67 | Maintains | Buy | Get Alert |
| 05/29/2024 | Buy Now | -12.18% | TD Cowen | Ritu Baral31% | $45 → $67 | Maintains | Buy | Get Alert |
| 05/29/2024 | Buy Now | -23.97% | UBS | Trung Huynh69% | $46 → $58 | Maintains | Buy | Get Alert |
| 05/29/2024 | Buy Now | -3% | Goldman Sachs | Andrea Tan44% | $49 → $74 | Maintains | Buy | Get Alert |
| 05/29/2024 | Buy Now | 0.93% | Wells Fargo | Tiago Fauth70% | $55 → $77 | Maintains | Overweight | Get Alert |
| 05/29/2024 | Buy Now | -10.87% | Truist Securities | Nicole Germino51% | $48 → $68 | Maintains | Buy | Get Alert |
| 05/29/2024 | Buy Now | -17.42% | Barclays | Leon Wang68% | $40 → $63 | Maintains | Overweight | Get Alert |
| 05/29/2024 | Buy Now | -27.91% | JP Morgan | Jessica Fye72% | $36 → $55 | Maintains | Overweight | Get Alert |
| 05/29/2024 | Buy Now | -18.73% | B of A Securities | Jason Zemansky74% | $40 → $62 | Maintains | Buy | Get Alert |
| 05/29/2024 | Buy Now | -8.24% | HC Wainwright & Co. | Andrew Fein62% | $52 → $70 | Maintains | Buy | Get Alert |
| 05/28/2024 | Buy Now | -21.35% | Morgan Stanley | Matthew Harrison32% | $43 → $60 | Maintains | Overweight | Get Alert |
| 05/28/2024 | Buy Now | -47.57% | B of A Securities | Jason Zemansky74% | $40 → $40 | Maintains | Buy | Get Alert |
| 05/16/2024 | Buy Now | -37.08% | Truist Securities | Nicole Germino51% | $48 → $48 | Maintains | Buy | Get Alert |
| 05/15/2024 | Buy Now | -35.77% | Goldman Sachs | Andrea Tan44% | $40 → $49 | Maintains | Buy | Get Alert |
| 05/14/2024 | Buy Now | -31.84% | HC Wainwright & Co. | Andrew Fein62% | $52 → $52 | Reiterates | Buy → Buy | Get Alert |
| 05/13/2024 | Buy Now | -52.81% | Mizuho | Graig Suvannavejh48% | $35 → $36 | Maintains | Buy | Get Alert |
| 05/10/2024 | Buy Now | -43.64% | Morgan Stanley | Matthew Harrison32% | $40 → $43 | Maintains | Overweight | Get Alert |
| 04/23/2024 | Buy Now | -37.08% | Truist Securities | Nicole Germino51% | → $48 | Initiates | → Buy | Get Alert |
| 04/11/2024 | Buy Now | -47.57% | Barclays | Leon Wang68% | $37 → $40 | Maintains | Overweight | Get Alert |
| 04/01/2024 | Buy Now | -27.91% | Wells Fargo | Tiago Fauth70% | $55 → $55 | Maintains | Overweight | Get Alert |
| 02/27/2024 | Buy Now | -29.22% | Guggenheim | Vamil Divan75% | $52 → $54 | Maintains | Buy | Get Alert |
| 02/27/2024 | Buy Now | -39.7% | UBS | Trung Huynh69% | → $46 | Initiates | → Buy | Get Alert |
| 02/23/2024 | Buy Now | -47.57% | B of A Securities | Jason Zemansky74% | $37 → $40 | Maintains | Buy | Get Alert |
| 02/15/2024 | Buy Now | -44.95% | Wolfe Research | Andy Chen41% | → $42 | Initiates | → Outperform | Get Alert |
| 11/20/2023 | Buy Now | -52.81% | JP Morgan | Jessica Fye72% | → $36 | Reinstates | → Overweight | Get Alert |
| 10/27/2023 | Buy Now | -54.12% | Mizuho | Graig Suvannavejh48% | $33 → $35 | Maintains | Buy | Get Alert |
| 09/21/2023 | Buy Now | -29.22% | Cantor Fitzgerald | Jennifer Kim47% | $46 → $54 | Maintains | Overweight | Get Alert |
| 09/19/2023 | Buy Now | -39.7% | Cantor Fitzgerald | Jennifer Kim47% | → $46 | Reiterates | Overweight → Overweight | Get Alert |
| 09/07/2023 | Buy Now | -44.95% | Evercore ISI Group | Josh Schimmer54% | $32 → $42 | Maintains | Outperform | Get Alert |
| 09/06/2023 | Buy Now | -56.74% | Mizuho | Graig Suvannavejh48% | $30 → $33 | Maintains | Buy | Get Alert |
| 09/06/2023 | Buy Now | -51.5% | B of A Securities | Jason Zemansky74% | $35 → $37 | Maintains | Buy | Get Alert |
| 09/06/2023 | Buy Now | -31.84% | HC Wainwright & Co. | Andrew Fein62% | → $52 | Reiterates | Buy → Buy | Get Alert |
| 09/05/2023 | Buy Now | -31.84% | Guggenheim | Vamil Divan75% | $50 → $52 | Reiterates | Buy → Buy | Get Alert |
| 08/04/2023 | Buy Now | -54.12% | Stifel | Stephen Willey54% | $33 → $35 | Maintains | Buy | Get Alert |
| 08/04/2023 | Buy Now | -46.26% | Morgan Stanley | Matthew Harrison32% | $41 → $41 | Reiterates | Overweight → Overweight | Get Alert |
| 08/04/2023 | Buy Now | -31.84% | HC Wainwright & Co. | Andrew Fein62% | → $52 | Reiterates | Buy → Buy | Get Alert |
| 07/26/2023 | Buy Now | -60.68% | Mizuho | Graig Suvannavejh48% | $28 → $30 | Maintains | Buy | Get Alert |
| 07/26/2023 | Buy Now | -34.46% | Guggenheim | Vamil Divan75% | → $50 | Initiates | → Buy | Get Alert |
| 05/09/2023 | Buy Now | -31.84% | HC Wainwright & Co. | Andrew Fein62% | → $52 | Reiterates | → Buy | Get Alert |
| 02/24/2023 | Buy Now | -39.7% | Cantor Fitzgerald | Jennifer Kim47% | $49 → $46 | Maintains | Overweight | Get Alert |
| 02/24/2023 | Buy Now | -39.7% | Credit Suisse | Judah Frommer15% | → $46 | Reiterates | → Outperform | Get Alert |
| 02/24/2023 | Buy Now | -31.84% | HC Wainwright & Co. | Andrew Fein62% | → $52 | Reiterates | → Buy | Get Alert |
| 01/20/2023 | Buy Now | -54.12% | Barclays | Leon Wang68% | $37 → $35 | Maintains | Overweight | Get Alert |
| 01/09/2023 | Buy Now | -48.88% | Goldman Sachs | Andrea Tan44% | $44 → $39 | Maintains | Buy | Get Alert |
| 12/09/2022 | Buy Now | -63.3% | Mizuho | Graig Suvannavejh48% | → $28 | Initiates | → Buy | Get Alert |
| 12/08/2022 | Buy Now | -51.5% | Barclays | Leon Wang68% | → $37 | Initiates | → Overweight | Get Alert |
| 12/07/2022 | Buy Now | -51.5% | Barclays | Leon Wang68% | → $37 | Initiates | → Overweight | Get Alert |
| 11/18/2022 | Buy Now | -48.88% | B of A Securities | Jason Zemansky74% | → $39 | Initiates | → Buy | Get Alert |
| 10/27/2022 | Buy Now | -34.46% | SVB Leerink | Joseph Schwartz12% | $52 → $50 | Maintains | Outperform | Get Alert |
| 10/25/2022 | Buy Now | -35.77% | Cantor Fitzgerald | Jennifer Kim47% | $53 → $49 | Maintains | Overweight | Get Alert |
| 10/21/2022 | Buy Now | -30.53% | Cowen & Co. | Ritu Baral31% | $56 → $53 | Maintains | Outperform | Get Alert |
| 07/15/2022 | Buy Now | -46.26% | Morgan Stanley | Matthew Harrison32% | $46 → $41 | Maintains | Overweight | Get Alert |
| 05/24/2022 | Buy Now | -37.08% | Goldman Sachs | Andrea Tan44% | $56 → $48 | Maintains | Buy | Get Alert |
| 04/27/2022 | Buy Now | -26.6% | Goldman Sachs | Andrea Tan44% | → $56 | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Insmed (INSM) stock?
The latest price target for Insmed (NASDAQ:INSM) was reported by B of A Securities on March 20, 2025. The analyst firm set a price target for $96.00 expecting INSM to rise to within 12 months (a possible 25.84% upside). 61 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Insmed (INSM)?
The latest analyst rating for Insmed (NASDAQ:INSM) was provided by B of A Securities, and Insmed maintained their buy rating.
When was the last upgrade for Insmed (INSM)?
There is no last upgrade for Insmed
When was the last downgrade for Insmed (INSM)?
There is no last downgrade for Insmed.
When is the next analyst rating going to be posted or updated for Insmed (INSM)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Insmed, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Insmed was filed on March 20, 2025 so you should expect the next rating to be made available sometime around March 20, 2026.
Is the Analyst Rating Insmed (INSM) correct?
While ratings are subjective and will change, the latest Insmed (INSM) rating was a maintained with a price target of $92.00 to $96.00. The current price Insmed (INSM) is trading at is $76.29, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.